Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

SoftOx Solutions

Less than 1K followers

SOFTX

Euronext Growth Oslo

Biotechnology & Pharmaceuticals

Health Care

Overview
Investor consensus

SoftOx Solutions is a Norwegian medical technology company. The company has developed a proprietary solution based on acetic acid for the treatment of chronic wounds in patients. The solution is used to eliminate infections associated with biofilms, which consist of different clusters of bacteria. Part of the drug development is done in collaboration with other research institutes. SoftOx Solutions was founded in 2012 and is headquartered in Oslo, Norway.

Read more
Market cap
-
Turnover
-
Revenue
7.91M
EBIT %
-410.37 %
P/E
-
Dividend yield-%
-
Financial calendar
15/12
2025

Extraordinary general meeting '25

5/3
2026

Annual report '25

24/6
2026

General meeting '26

All
Press releases
ShowingAll content types
Regulatory press release12/5/2025, 5:11 PM

SoftOx Solutions AS: New Share Capital

SoftOx Solutions
Regulatory press release11/28/2025, 1:32 PM

SoftOx Solutions AS: Notice of Extraordinary General Assembly

SoftOx Solutions
Regulatory press release11/28/2025, 1:31 PM

SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited

SoftOx Solutions

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release11/26/2025, 7:00 AM

SoftOx Solutions AS: Third Quarter Report 2025

SoftOx Solutions
Regulatory press release11/14/2025, 7:35 AM

SoftOx Solutions AS: GMP Drug Substance Successfully Manufactured - Key Milestone for CF and EDF Clinical Programs

SoftOx Solutions
Regulatory press release10/16/2025, 10:26 AM

SoftOx Solutions AS: SoftOx submits Phase 1 Clinical Trial Application under the European Defence Fund (EDF) Program

SoftOx Solutions
Regulatory press release10/13/2025, 6:11 AM

SoftOx Solutions AS: New Share Capital

SoftOx Solutions
Regulatory press release10/7/2025, 7:17 PM

SoftOx Solutions AS: Private Placement resolved

SoftOx Solutions
Regulatory press release10/3/2025, 1:23 PM

SoftOx Solutions AS: New Share Capital

SoftOx Solutions
Regulatory press release10/1/2025, 12:35 PM

SoftOx Solutions AS: Clinical Trial Application for Dose Escalation / Cystic Fibrosis Phase 2a - Important Milestone Achieved

SoftOx Solutions
Regulatory press release9/25/2025, 3:51 PM

SoftOx Solutions AS: Clarification on Placement Commission

SoftOx Solutions
Regulatory press release9/25/2025, 1:08 PM

SoftOx Solutions AS: Private Placements resolved

SoftOx Solutions
Regulatory press release9/23/2025, 7:07 AM

SoftOx Solutions AS: SoftOx builds momentum: CF trial strategy reinforced by HOCl stability breakthrough

SoftOx Solutions
Regulatory press release9/23/2025, 6:00 AM

SoftOx Solutions AS: SoftOx builds momentum: CF trial strategy reinforced by HOCl stability breakthrough

SoftOx Solutions
Regulatory press release9/17/2025, 6:00 AM

SoftOx Solutions AS: Second Quarter/Half-Year Report 2025

SoftOx Solutions
Regulatory press release9/11/2025, 1:59 PM

SoftOx Solutions AS: Softox Solutions AS exercises on the financing facility with Long State Investments Limited

SoftOx Solutions
Regulatory press release9/8/2025, 10:07 AM

SoftOx Solutions AS: Presentation Deck and link to today's Investor Update

SoftOx Solutions
Regulatory press release9/8/2025, 6:00 AM

SoftOx Solutions AS: Reminder - Investor Update in connection with the Refinement of the Clinical Focus into Chronic Lung Disease Treatment

SoftOx Solutions
Regulatory press release9/3/2025, 10:39 AM

SoftOx Solutions AS: Investor Update in connection with the Refinement of the Clinical Focus into Chronic Lung Disease Treatment

SoftOx Solutions
Regulatory press release9/2/2025, 6:59 AM

SoftOx Solutions AS: Refines Clinical Focus and Advances Into Chronic Lung Disease Treatments

SoftOx Solutions
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.